Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.
Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.
A class of type 2 diabetes drugs, which includes the brand names Victoza and Byetta, may help curb alcohol addiction and could pave the way for wider usage of the medications, according to a new study. However, it could also expose more people to potentially deadly side effects. Victoza and Byetta are in a class of drugs known as GLP-1 agonists. They work by mimicking the functions of the natural incretin hormones in the body that help lower post-meal blood sugar levels. These functions include stimulating the release of insulin by the pancreas after eating, inhibiting the release of glucagon ... Read More
Drugs from a new class of blood thinners are gaining traction in sales, but analysts say they have a lot to prove before doctors push aside the long-used warfarin for the new drugs. The new blood thinners are from a class known as factor Xa inhibitors and include the brand names Pradaxa, Xarelto and Eliquis. They have been approved sometime within the past five years and are used to prevent strokes caused by blood clots in patients with a common heart rhythm abnormality called atrial fibrillation. Xarelto and Eliquis are also used to treat and prevent blood clots in various ... Read More
European drug regulators have approved Regeneron Pharmaceuticals and Sanofi’s novel new non-statin, cholesterol-lowering medication, Praluent. The drug, known as a PCSK9 inhibitor, can be used alone or in combination with statins or other lipid-lowering therapies in patients with high LDL cholesterol. The U.S. Food and Drug Administration (FDA) approved Praluent in July, and a second PCSK9 inhibitor, Repatha made by Amgen, a month later. Repatha was approved by the European Commission in July. PCSK9 inhibitors work by targeting and suppressing a particular gene involved in the regulation of how much cholesterol the liver filters out. The drugs are designed as ... Read More
Computer-aided technology by Hologic Inc. and Icad Inc., used in 90 percent of mammograms performed in the United States for breast cancer screenings, failed to find more tumors than mammograms without the computerized assistance, a new study has found. “There is absolutely no question from our research that computer-aided detection offers no benefit to catching cancers that otherwise would have been missed or improving performance,” said Constance Lehman, the study’s lead researcher and director of breast imaging and co-director of the Avon Foundation Comprehensive Breast Evaluation Center at Massachusetts General Hospital in Boston. “We should certainly stop charging for it. ... Read More
Novo Nordisk has seen success with its type 2 diabetes drug Victoza. But a different indication for the medication, which sprang from a Victoza side effect, may prove to be even more profitable for the drug company. Victoza, which contains the drug ingredient liraglutide, is a once-daily injection to treat Type 2 diabetes. It was approved by the Food and Drug Administration (FDA) in January 2010. It is in the same drug class as the diabetes medications Byetta and Januvia. One side effect from these medications is weight loss, which prompted Novo Nordisk to begin testing the drug in higher doses ... Read More
The Food and Drug Administration (FDA) has issued a Safety Communication warning that medical devices used to cut and drill the bones of the skull in some cases have not automatically stop drilling after penetrating the skull and have unintentionally drilled, or plunged, into the brain causing serious and life threatening injuries. Most cranial perforators are designed to stop drilling once the device has penetrated the skull. However, if proper use, patient considerations, and device selection are not followed in accordance with the manufacturers’ instructions for use, the clutch mechanism may fail to disengage. From January 2005 through August 2015, the ... Read More
Many of us have no choice but to trust that when we go to the hospital for a medical procedure, we won’t end up with some frightening disease. We assume in this day and age that cleaned and disinfected surgical tools are safe. But recent news of drug resistant superbugs and deadly mad cow-like diseases linked to reusable medical devices have left many people asking why hospitals don’t use more stringent cleaning practices, and why manufacturers of these surgical tools don’t redesign them so they don’t harbor deadly bacteria and risk sickening others. The Food and Drug Administration (FDA) recently ... Read More
Another Bayer contraceptive may be injuring women. On Thursday, several women gave emotional testimonies to a Food and Drug Administration (FDA) advisory panel urging them to pull a permanent birth control implant off the market because they say it causes chronic pain and other injuries. The Essure implant, made by Bayer, is the only non-surgical FDA-approved permanent birth control device on the market. It is comprised of two small, metal coils, one of which is inserted into each of the fallopian tubes. They are designed to encourage the growth of scar tissue, which blocks the sperm from reaching the egg. About 750,000 women have ... Read More
The controversial blood thinner Xarelto has been granted clearance by Japanese drug regulators for expansion of the drug’s usage to include the treatment and secondary prevention of pulmonary thromboembolism (PE) and deep vein thrombosis (DVT). DVT is a condition in which blood clots form in one of the large, deep veins, generally in the legs. PE is a condition that occurs when a blood clot travels to the lungs and partially or completely block a branch of a pulmonary artery. PE can be fatal if the blood clot is large, there are multiple clots, or if the patient has heart or ... Read More
Steve Schabel, a married father of three, said he began testosterone therapy in 2013 to treat depression and boost his sex drive. He started with the gel and then switched to an injection. A week later, he was hospitalized with a life threatening double pulmonary embolism, or blood clots in the lungs. Shabel had no prior history of heart problems. He has recovered but must take blood thinners for the rest of his life. He is now one of several men who is suing the manufacturer of his testosterone replacement treatment claiming the company engaged in questionable marketing practices to ... Read More